Insufficiency of surfactants is a core factor in respiratory distress syndrome, which causes apnea and neonatal death, particularly in preterm infants. Surfactant proteins are secreted by alveolar type II cells in the lung epithelium, the differentiation of which is regulated by Fgf10 elaborated by the adjacent mesenchyme. However, the molecular regulation of mesenchymal Fgf10 during lung development has not been fully understood. Here, we show that Pbx1, a homeodomain transcription factor, is required in the lung mesenchyme for the expression of Fgf10. Mouse embryos lacking Pbx1 in the lung mesenchyme show compact terminal saccules and perinatal lethality with failure of postnatal alveolar expansion. Mutant embryos had severely reduced expression of Fgf10 and surfactant genes (Spa, Spb, Spc, and Spd) that are essential for alveolar expansion for gas exchange at birth. Molecularly, Pbx1 directly binds to the Fgf10 promoter and cooperates with Meis and Hox proteins to transcriptionally activate Fgf10. Our results thus show how Pbx1 controls Fgf10 in the developing lung. genesis 52:399-407, 2014. V C 2014 Wiley Periodicals, Inc.
INTRODUCTION
Abnormalities in alveolar surfactant synthesis can cause respiratory distress syndrome (RDS), which affects 1% of the newborns and is the leading cause of death in preterm infants (Ballard et al. 2003; Clements and Avery, 1998; Rodriguez et al., 2002) . RDS usually develops in the first 24 h after the birth of premature babies with developmental insufficiency of pulmonary surfactant synthesis and structurally immature lungs (Clements and Avery, 1998; Gower and Nogee, 2011; Rodriguez et al., 2002; Yurdakok, 2004) . Genetic abnormalities of producing surfactant proteins (Spa, Spb, Spc, and/or Spd) can result in this syndrome (Beers et al., 2000; Gower and Nogee, 2011; Nkadi et al., 2009; Nogee, 2004) .
Pulmonary surfactant is a surface-active lipoprotein complex (phospholipoprotein) secreted by alveolar type II cells in the lung (Hawgood, 2004; Nogee, 2004; Whitsett and Weaver, 2002) . The surfactant, comprised of proteins and lipids with hydrophilic and hydrophobic regions, reduces the surface tension of the alveoli and thereby facilitate and maintain the expansion of the lung (Cardoso, 2001; Halliday, 2008; Mendelson, 2000) . During lung development, the fibroblast growth factor Fgf7 and Fgf10 are secreted from the mesenchyme to activate the proliferation of adjacent alveolar type II cells that express the surfactant genes (Spa, Spb, Spc, and Spd; Cardoso et al., 1997; Chelly et al., 1999; Hyatt et al., 2004; Mason et al., 2002; Ramasamy et al., 2007) , and the differentiation of lung epithelial progenitors is also regulated by Fgf10 produced by the distal mesenchyme (Volckaert et al., 2013) .
Our studies demonstrate that the transcription factor Pbx1 functions within the lung mesenchyme to regulate Fgf10 expression. Pbx1 belongs to the family of TALE (three amino acid loop extension)-class homeodomain transcription factors that cooperate with Hox and Meis homeodomain proteins to regulate target gene expression (Chang et al., 1995 (Chang et al., , 1996 . In embryos, Pbx1 partners with Meis/Hox proteins to facilitate the patterning of great arteries and cardiac outflow tract (OFT; Chang et al., 2008; Stankunas et al., 2008b) . Here, we show that mice lacking Pbx1 in the lung mesenchyme display neonatal death with inability of lung expansion and consequent respiratory failure. Transcriptional regulation of Fgf10 by Pbx1 regulates the crosstalk between lung mesenchyme and alveolar epithelium during lung development.
RESULTS

Islet1Cre; Pbx1 f/f Mice Die at Birth
Pbx1-null (Pbx1 2/2 ) mice display defects in the septation of aorta and pulmonary artery (Chang et al., 2008) . To study Pbx1 function in cardiac progenitor cells for aortopulmonary septation, we deleted Pbx1 by crossing mice carrying a loxP-flanked allele of Pbx1 (Pbx1 f ) with mice harboring Islet1Cre, whose Cre activity is present in cardiac progenitor cells of the secondary heart field essential for cardiac OFT development (Cai et al., 2003) . Mutant Islet1Cre;Pbx1 f/f embryos developed grossly normal up to birth without changes in weight, but the pubs died immediately after birth ( Fig. 1a -e; data not shown).
The Lungs of Islet1Cre;Pbx1 f/f Mice Fail to Expand at Birth
To determine the cause of lethality, we dissected the newborn pubs at P0 and found that Islet1Cre;Pbx1 f/f mice failed to expand the lungs and contained no air in the lungs ( Fig. 2a,b ). Neither was there expansion of or air in the lungs of Islet1Cre;Pbx1 f/f pups after caesarian section at E18.5 ( Fig. 2c,d ). The casting of airways at E17.5 showed that the airway structure was normal in Islet1Cre;Pbx1 f/f embryos ( Fig. 2e-h) . These findings suggest that the absence of gas exchange in the lungs of mutant mice may contribute to the death of mutant pubs. We then examined the development of embryos. At E13.5, the cardiac OFT of Islet1Cre;Pbx1 f/f mice was normally separated into aorta and main pulmonary artery ( Fig. 2i,j) . Furthermore, there were no gross abnormalities of brain, heart, kidney, liver, stomach, intestine, esophagus, trachea, and thymus (data not shown). These observations suggest a defect in lung development that may lead to neonatal lethality of the Islet1Cre;Pbx1 f/f mice.
Pbx1 is Essential for Lung Development
We examined the morphology and histology of lungs of the Islet1Cre;Pbx1 f/f mice. At birth (P0), the lungs of mutant mice had normal number of lung lobes (data not shown) but were grossly smaller in size ( Fig. 3a,b ) and didn't have any air in the alveoli ( Fig. 2a,b ). At E16.5, the lungs of mutant mice showed compacted terminal saccules ( Fig. 3c,d ). However, the mutant lungs were normal in weight ( Fig. 3e ).
We then asked if Pbx1 was absent in the lungs of Islet1Cre;Pbx1 f/f mice and used immunostaining to directly examine Pbx1 protein distribution in the lung tissues of mutant mice. Interestingly, in the normal E16.5 lungs, Pbx1 proteins were abundant in the lung mesenchyme but absent in the epithelium (Fig. 3f ). In contrast, in the lungs of E16.5 Islet1Cre;Pbx1 f/f mice, Pbx1 proteins were nearly absent in the lung mesenchyme ( Fig. 3g ), suggesting that IsletCre directs the deletion of Pbx1 in lung mesenchymal cells and that Pbx1 is essential in lung mesenchymal cells for alveolar expansion at birth.
Because surfactant proteins produced by alveolar type II cells are critical for forming a lipoprotein complex in the alveoli to lower surface tension and enable alveolar expansion for gas exchange (Mendelson, 
2000)
, we tested the expression of genes encoding the surfactant proteins in the lungs. By RT-qPCR, we found that the expression of surfactant genes2Spa, Spb, Spc, and Spd2was reduced by 36-72% in the lungs of Islet1-Cre;Pbx1 f/f mice (Fig. 3h ). Western blot of these mutant embryos also showed a dramatically reduction of all surfactant proteins in Pbx1 deleted lungs ( Fig. 3i ). Such compound reduction of all surfactants provides an explanation for the failure of postnatal alveolar expansion in the mutant mice.
Pbx1 is Essential for Fgf10 Expression in the Lung Mesenchyme
We next questioned how Pbx1 expressed in the lung mesenchyme controlled the surfactant genes that are expressed by alveolar type II cells (Mendelson, 2000) . During lung development, the growth factors of Fgf7 and Fgf10 are secreted from the mesenchyme to activate the proliferation of alveolar type II cells that express surfactant genes (Spa, Spb, Spc, and Spd; Cardoso et al., 1997; Chelly et al., 1999; Hyatt et al., 2004; Mason et al., 2002; Ramasamy et al., 2007) . Furthermore, localized Fgf10 expression in the mesenchyme is essential for the differentiation of lung epithelial progenitors in vivo (Volckaert et al., 2013) . In addition, the semaphorin-3a protein (Sema3a) is expressed by the mesenchyme to negatively regulate the size and shape of the emerging saccules (Cirulli and Yebra, 2007; Ito et al., 2000) . Given that Fgf7, Fgf10, and Sema3a are expressed in the lung mesenchyme (Cirulli and Yebra, 2007) , we tested if the mesenchymal Pbx1 was required for their expression. By RT-qPCR, we found that Fgf10 showed a 65% decrease of mRNA level (P < 0.0001) in mutant lungs; the other two genes had no changes ( Fig. 4a ). Western blot and immunostaining of Islet1Cre;Pbx1 f/f embryos showed a severe reduction of Fgf10 proteins in Pbx1 deleted lungs ( Fig. 4b-d ). These findings suggest that Pbx1 in the lung mesenchyme is essential for activating Fgf10 expression in the lungs.
Pbx1 Cooperates with Hox and Meis Proteins to Transcriptionally Activate Fgf10
To test whether Pbx1 directly regulated Fgf10 expression, we used chromatin-immunoprecipitation and quantitative PCR (ChIP-qPCR) to examine the binding of Pbx1 to the Fgf10 promoter. With sequence analysis by TFSEARCH software (www.cbrc.jp), we identified 5 regions (F1-F5) that contained potential Pbx1 binding sites in the proximal 4 kb promoter of mouse Fgf10 (Fig. 4e ). ChIP-qPCR analyses of mouse E16.5 lungs (about 10 embryonic lungs were required for each ChIP experiments) using anti-Pbx1 antibody (Chang et al., 1997 (Chang et al., , 2008 showed that Pbx1 proteins were enriched within the F1-F5 regions, but not a negative control region (NC), of Fgf10 (Fig. 4f ). There was also no enrichment of Pbx1 in a negative control site on the Admst1 promoter (Stankunas et al., 2008a; Fig. 4f ). The ChIP assay therefore demonstrates that Pbx1 proteins are associated with Pbx1 binding sites in the proximal promoter of Fgf10 in the lungs.
To study the transcriptional activity of Pbx1 on the Fgf10 promoter, we cloned the full-length proximal Fgf10 promoter (23905, 1246) into a luciferase reporter plasmid pREP4 (Hang et al., 2010) . The Fgf10 reporter plasmid and Pbx1, Meis1, and/or HoxB4 expressing plasmids (Chang et al., 1995 (Chang et al., , 1996 (Chang et al., , 2008 were cotransfected into a human lung carcinoma cell line H1299 for transient transactivation of reporter activities. By measuring the luciferase activity driven by Fgf10 reporter, we found that Pbx1 modestly increase the Fgf10 promoter activity by 30%. However, in the presence of Pbx1's partners Meis1 and HoxB4 (Chang et al., 1995 (Chang et al., , 1997 , Pbx1 enhanced the Fgf10 promoter activity by 8.14-fold ( Fig. 4g ), suggesting synergistic interactions among Pbx, Meis, and Hox transcription factors in the activation of Fgf10. These results, together with the ChIP analysis, indicate a direct transcriptional activation of Fgf10 by Pbx1 and its cofactors.
DISCUSSION
By using Islet1Cre to delete Pbx1, we serendipitously found that Pbx1 is essential in the lung mesenchyme to transcriptionally activate the expression of Fgf10, which encodes an essential factor for the differentiation of epithelial progenitors (Volckaert et al., 2013; Fig. 4h ). Our studies suggest that Pbx1 cooperates with Meis and Hox proteins to control Fgf10 expression in the lung mesenchyme. Disruption of Pbx1 in the lung mesenchyme interrupts the Pbx1-Fgf10 pathway, causing failure of alveolar expansion at birth and subsequent neonatal lethality.
Although Islet1 is a marker of cardiac progenitor cells derived from the second heart field (Cai et al., 2003) , Islet1 is not restricted to second heart field progenitors. It also labels the neural crest and lungs, including the lung mesenchymal cells. The expression of Islet1 in those tissues has been documented by lineage tracing using Islet1Cre with a Rosa26 lacz reporter allele (Engleka et al., 2012; High et al., 2009; Yu et al., 2010) . Furthermore, the unexpected normal heart morphogenesis of Islet1Cre Pbx1 f/f mice could be the result of the following factors. First, Pbx1 may not function in the secondary heart field for regulating aortopulmonary septation. Pbx1 may work in cell types not labeled by Islet1Cre. Second, because a time delay exists between Cre expression and gene deletion, the deletion of Pbx1 by Islet1Cre may occur after the major actions of Pbx1 in cardiac progenitor cells have completed, thereby generating no cardiac phenotype. Further studies using other Cre lines to define the site and the time of Pbx1 action for heart development are essential to understand the cardiac function of Pbx1.
In embryos, active chloride and fluid secretions across the airway epithelium are essential for normal lung morphogenesis (Blaisdell et al., 2000) . The compacted lungs of Islet1Cre Pbx1 f/f embryos suggest that Pbx1 may also regulate chloride and fluid secretion during lung development. Further studies are needed to elucidate the mechanism. In contrast, the neonates require surfactants to allow the expansion of alveoli at birth. Surfactant proteins are lipoproteins that serve a key role in the adsorption and spreading of fluid at the alveolar air-liquid interface (Veldhuizen et al., 1998) . Surfactants include four proteins, Spa, Spb, Spc, and Spd (Mendelson, 2000) , the abnormalities of which in mice or patients can cause RDS, which affects 1% of the newborn and is the leading cause of death in preterm infants (Ballard et al. 2003; Clements and Avery 1998; Rodriguez et al., 2002) . The lungs of Spa2/2 mice were susceptible to infections (Ikegami et al., 1998) , and human SPA was shown to be anti-inflammatory (Lee et al., 2010) , suggesting that Spa is important for immune defense within the alveoli. Furthermore, both Spb2/2 mice (Clark et al., 1995) and SPB-deficient infants (Nogee et al., 1993) displayed RDS phenotype. Interestingly, with the Spb deficiency, Spc is abnormally processed and immature, resulting in an additional reduction of surfactant function with consequent severe RDS phenotype (Vorbroker et al., 1995) . These studies indicate the necessity of Spb and Spc for alveolar function. In contrast, Spd2/2 mice developed a progressive accumulation of surfactant lipids within the alveoli, suggesting a critical role of Spd in surfactant homeostasis (Botas et al., 1998) .
The expression of surfactant genes in the developing lungs is regulated by many factors, including cyclic AMP, glucocorticoids, retinoids, insulin, growth factors, and cytokines (EGF, TGF, TNF, IFN, and Interleukin) (Mendelson, 2000; Mendelson et al., 1998) . Furthermore, Fgf10 is critical for the proliferation of alveolar type II cells that secrete Spa, Spb, Spc, and Spd (Mason et al., 2002; Ramasamy et al., 2007) , the reprogramming of mouse tracheal epithelium to express Spc in vitro (Hyatt et al., 2004) , as well as the regulation of lung epithelial progenitors in vivo (Volckaert et al., 2013) . The expression of Fgf10 is regulated by both Pbx1 (this studies) and Shh (Bellusci et al., 1997b; Murone et al., 1999; Pepicelli et al., 1998) . Pbx1 in the mesenchymal cells is required for Fgf10 expression, whereas Shh secreted from the alveolar epithelium binds to its receptor Patched on the mesenchymal cells to suppress Fgf10 expression. Absence of Pbx1 in mesenchymal cells or overexpression of Shh driven by Spc enhancer/promoter in embryonic lungs resulted in Fgf10 reduction, compaction of terminal saccules, and neonatal lethality (this studies; Bellusci et al., 1997a) . In contrast to mice lacking Pbx1, mouse embryos deficient in Shh had enhanced expression of Fgf10 in the lung (Pepicelli et al., 1998) . Shh and Pbx1 therefore appear to form a negative feedback loop between alveolar and mesenchymal cells to regulate the level of Fgf10 in the developing lung (Fig. 4h ). Further analyses of the interactions between Shh signaling and the Pbx-Fgf10 pathway will be crucial to provide a deeper insight into the molecular mechanisms underlying lung mesenchymal and epithelial development.
Our studies have clinical implications. Mice with deletion of Pbx1 in the lung mesenchyme can provide an animal model to study the mechanisms that underlies RDS. Recently, two single nucleotide genetic mutations in PBX1 were observed in women with Mullerian duct abnormalities (Ma et al., 2011) . It will be interesting for future investigations to determine whether PBX1 mutations could also underlie RDS in some patients.
METHODS
Mice
Pbx1 f/f (Koss et al., 2012) and Islet1Cre (Cai et al., 2003; Yang et al., 2006) mice have been described previously. The date of observing a vaginal plug was set as E0.5, and embryonic development was confirmed by ultrasonography before sacrificing pregnant mice (Chang et al., 2003) . The use of mice for studies is in compliance with the regulations of Stanford University and National Institute of Health.
Histology, Immunostaining, and Airway Casting
Histological analysis and immunostaining were performed as described (Chang et al., 2004 (Chang et al., , 2008 . All these procedures were performed on 7 mm paraffin sections of the lungs which were freshly prefixed by 4% PFA. Hematoxylin and eosin (H&E) stain was performed according to standard protocols. The following primary antibodies were used for immunostaining: anti-Pbx1 antibody (41.1, a gift from Dr. M. Cleary, dilution 1:100), anti-Fgf10 (AF6224, R&D systems, dilution 1:40). Airway casting with an acrylic resin (Batson no. 17) containing blue dye (Methyl Methacrylate Casting Kit, Polyscience) was performed as described (Chang et al., 2008) .
RNA Isolation and Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR)
Total RNA was extracted using TRIZOL followed by RNase-free DNase I treatment (NEB) to avoid genomic contamination. Total RNA (1 mg for each sample) was reverse transcribed by iScript (BioRad, Hercules, CA) and quantitative real time PCR analysis was performed using SYBR Green supermix (BioRad, Hercules, CA) or Taqman reagents (Applied Biosciences) according to manufacturer's recommendations. Murine Pbx1 and Gapdh were by Taqman probes (Applied Biosciences, Foster City, CA). The other primer sets used were tested to be quantitative: Chromatin Immunoprecipitation-Quantitative PCR (ChIP-qPCR) The ChIP procedure was described previously (Hang et al., 2010; Stankunas et al., 2008a) . Chromatin from E16.5 lungs (about 10 embryos for each ChIP) was sonicated to an average length between 200 and 500 base pairs, and immunoprecipitated using anti-Pbx1 antibody (41.1, a gift from Dr. M. Cleary), or control IgG; 5% of the pull down was taken for subsequent qPCR analysis. ChIP-qPCR signals of individual ChIP reaction was standardized to its own input qPCR signals. PCR primers for the potential Pbx1 binding regions on Fgf10 promoter: F1-F GTC CCTGATTTCATTTGCGCC, F1-R CTCGCTTCCGTTG CTGAAGTA; F2-F GGGAGTGTTGGGCTGAAGAAG, F2-R AGTTTGGGGTTTCTTTACACTGGA; F3-F ATGT-CAGCTTTTCCTTTGGGCA, F3-R GCAATGTTTGA GGGTTCCCGA; F4-F CGTCGAATTTAACAGCAGCT-TACC, F4-R GCTGTCTGTCTCTTTCATCCGA; F5-F TT CCTATGGCTGGGTTGCCTA, F5-R ATCAACCACGTTG-GAGCTCAG. Control primers for the region without potential Pbx1 binding site on Fgf10 promoter: NC-F CCAGAACACAGATGTCTAACT, NC-R TGAGTACCAGA-GATCATTTCC. Control primers for promoter of Admst1 were described previously (Stankunas et al., 2008a) . The DNA positions are denoted relative to the transcriptional start site (11).
Cloning and Luciferase Reporter Assay
The reporter assays were previously described (Chang et al., 2008; Hang et al., 2010; Wu et al., 2007) . Full length of intergenic Fgf10 promoter which span (23905, 1246) was cloned into pREP4-Luc reporter plasmid (Liu et al., 2001) . These constructs were then transfected into a human lung carcinoma cell line H1299 with lipofectamine 2000 (Invitrogen, Carlsbad, CA) along with pREP7-RL as a transfection efficiency control, Pbx1, Meis1, and HoxB4 expression vectors (Chang et al., 2008) with the appropriate empty vector control. Luciferase activity was measured and normalized to a cotransfected Renilla luciferase construct using the Dual-Luciferase Reporter System (Promega, Madison, WI).
